SCHEMBL9849946

SCHEMBL9849946

CC(Cl)/C(=C\C=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ATM Q13315 4/20 0.36
LMNA P02545 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MAPT P10636 1/20 0.36
XBP1 P17861 1/20 0.36
HSP90AA1 P07900 2/20 0.36
GAA P10253 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TSHR P16473 2/20 0.33
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
TP53 P04637 2/20 0.33
HPGD P15428 2/20 0.33
DAO P14920 1/20 0.33
NAPRT Q6XQN6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22423740 0.84 ALDH1A1 (0.40) ALDH1A1MAPK1TDP1ATMLMNA
SCHEMBL27552212 0.70 ALDH1A1 (0.35) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL27278216 0.69 TDP1 (0.40) ALDH1A1MAPK1TDP1LMNASMN1; SMN2
SCHEMBL10716596 0.69 ATM (0.55) ALDH1A1TDP1ATMLMNASMN1; SMN2
SCHEMBL1307988 0.69 ALDH1A1 (0.44) ALDH1A1MAPK1TDP1MAPTTSHR
SCHEMBL7365926 0.69 MEN1 (0.46) ALDH1A1MAPK1TDP1LMNASMN1; SMN2
SCHEMBL186779 0.69 ALDH1A1 (0.44) ALDH1A1MAPK1TDP1MAPTTSHR
SCHEMBL560304 0.69 MEN1 (0.46) ALDH1A1MAPK1TDP1LMNASMN1; SMN2
SCHEMBL566341 0.69 ALDH1A1 (0.44) ALDH1A1MAPK1TDP1MAPTTSHR
SCHEMBL2098803 0.69 MEN1 (0.46) ALDH1A1MAPK1TDP1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0449699-A2 Pyrazole derivatives as angiotensin II-receptor antagonists, process for their preparation and pharmaceutical compositions containing them LABORATOIRES UPSA (FR) 1991-10-02 EP disclosed